Correlation Between Pfizer and Cboe Validus
Can any of the company-specific risk be diversified away by investing in both Pfizer and Cboe Validus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Cboe Validus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Cboe Validus SP, you can compare the effects of market volatilities on Pfizer and Cboe Validus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Cboe Validus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Cboe Validus.
Diversification Opportunities for Pfizer and Cboe Validus
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Pfizer and Cboe is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Cboe Validus SP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cboe Validus SP and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Cboe Validus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cboe Validus SP has no effect on the direction of Pfizer i.e., Pfizer and Cboe Validus go up and down completely randomly.
Pair Corralation between Pfizer and Cboe Validus
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Cboe Validus. In addition to that, Pfizer is 1.09 times more volatile than Cboe Validus SP. It trades about -0.11 of its total potential returns per unit of risk. Cboe Validus SP is currently generating about 0.09 per unit of volatility. If you would invest 2,072 in Cboe Validus SP on October 22, 2024 and sell it today you would earn a total of 20.96 from holding Cboe Validus SP or generate 1.01% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Cboe Validus SP
Performance |
| Timeline |
| Pfizer Inc |
| Cboe Validus SP |
Pfizer and Cboe Validus Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Cboe Validus
The main advantage of trading using opposite Pfizer and Cboe Validus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Cboe Validus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cboe Validus will offset losses from the drop in Cboe Validus' long position.The idea behind Pfizer Inc and Cboe Validus SP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Cboe Validus vs. Tidal Trust II | Cboe Validus vs. Draco Evolution AI | Cboe Validus vs. ProShares VIX Mid Term | Cboe Validus vs. ProShares VIX Short Term |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |